Bilateral interstitial pneumonia in acute lymphoblastic leukemia

Area of Science:

• Pediatric Oncology
• Pulmonology
• Infectious Diseases

Background:

• Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
• Bilateral interstitial pneumonia (BIP) is a serious complication observed in ALL patients.
• Understanding the incidence and etiology of BIP in ALL is crucial for patient management.

Purpose of the Study:

• To determine the incidence of BIP in children diagnosed with ALL.
• To identify potential etiologic factors contributing to BIP in this patient population.
• To assess the clinical outcomes and mortality associated with BIP in ALL.

Main Methods:

• Retrospective review of medical records for 148 children with ALL.
• Analysis of 34 cases diagnosed with bilateral interstitial pneumonia (BIP).
• Review of laboratory data, histopathology from lung biopsies and autopsies.

Main Results:

• The incidence of BIP in ALL patients was 22.9% at the Children's Hospital of Michigan.
• Most BIP episodes (82%) occurred within the first six months of ALL diagnosis, predominantly in the first three months.
• Laboratory and histopathologic findings suggested a viral etiology; Pneumocystis carinii infection was rare, and methotrexate hypersensitivity was not supported.

Conclusions:

• Bilateral interstitial pneumonia (BIP) is a significant complication in pediatric acute lymphoblastic leukemia (ALL) with a notable incidence (22.9%) and mortality (10.3%).
• The majority of BIP cases occur early in the course of ALL treatment, suggesting a link to the disease or its initial management.
• Viral infections are implicated as the primary cause of BIP in ALL patients, necessitating further investigation into specific pathogens and preventative strategies.